---
figid: PMC9166453__40035_2022_307_Fig2_HTML
figtitle: 'Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative
  diseases'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Caenorhabditis elegans
- gut metagenome
- prion
- Agriosomyces longus
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Caenorhabditis elegans
- Drosophila melanogaster
pmcid: PMC9166453
filename: 40035_2022_307_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9166453/figure/Fig2/
number: F2
caption: 'Schematic drawing of different possible neuroprotective mechanisms exerted
  by hydrophilic bile acids, with specific reference to the anti-apoptotic effects
  of TUDCA on different intracellular pathways. Factors and pathways inhibited by
  TUDCA are shown in red; pathways blocked by TUDCA are shown by a red cross; genes
  downregulated by TUDCA are shown by a red downward arrow. Proposed mechanisms of
  action of TUDCA include: inhibition of the intrinsic mitochondrial apoptotic pathway,
  through reduction of ROS and inactivation of BAX, in turn decreasing cytochrome
  c release; inhibition of the death receptor in the extrinsic apoptotic pathway,
  with further block of caspase 3; reduction of ER-mediated stress by decreasing caspase
  12 activity and Ca2+ efflux decrease from the ER. TUDCA also inhibits the apoptotic
  induced pathways MAPK, JNK, PI3K, NF-кB, ERK and p38 [–]. Furthermore, TUDCA is
  supposed to reduce the expression of genes involved in cell cycle regulation (Cyclin
  D1), the Apaf-1 apoptotic pathway, and the E2F/p53/BAX, and AP-1 pathways [, ].
  Abbreviations: AKT, protein kinase B; AP1, activating Protein-1; Apaf-1, apoptotic
  protease activating factor-1; ATF2, activating transcription factor 2; BAK, Bcl-2
  homologous antagonist killer; BAX, Bcl2-associated X protein; Bcl-2, B-cell lymphoma
  2 family of regulator proteins; BID, BH3 interacting-domain death agonist C, cytochrome
  C; CDC42, cell division control protein 42; E2F-1, E2 promoter binding factor 1;
  ERK, extracellular signal-regulated kinase; IKK-α, nuclear factor kappa-B kinase
  subunit alpha; IKK-β, nuclear factor kappa-B kinase subunit beta; IKK-γ, nuclear
  factor kappa-B kinase subunit gamma; JNK, c-Jun N-terminal kinase; KRAS, Kirsten
  rat sarcoma viral oncogene; MAPKs, mitogen-activated protein kinase; MOM, mitochondrial
  outer membrane; mTOR, mammalian target of rapamycin; NF-ĸB, nuclear factor kappa
  B; P, phosphate; p53, cellular tumour antigen p53; PI3K, phosphoinositide 3-kinases;
  RAC, Rho family of GTPases; RAS, rat Sarcoma Virus; SRF, serum response factor;
  tBID, truncated BID; TCF, transcription factor; TLR, Toll-like Receptor; TUDCA,
  tauroursodeoxycholic acid'
papertitle: 'Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative
  diseases.'
reftext: Kareem Khalaf, et al. Transl Neurodegener. 2022;11:33.
year: '2022'
doi: 10.1186/s40035-022-00307-z
journal_title: Translational Neurodegeneration
journal_nlm_ta: Transl Neurodegener
publisher_name: BioMed Central
keywords: Amyotrophic lateral sclerosis | Alzheimer’s disease | Bile acids | Disease-modifying
  | Huntington’s disease | Neurodegeneration | Neuroprotection | Parkinson’s disease
  | Ursodeoxycholic acid | Tauroursodeoxycholic acid
automl_pathway: 0.9421341
figid_alias: PMC9166453__F2
figtype: Figure
redirect_from: /figures/PMC9166453__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9166453__40035_2022_307_Fig2_HTML.html
  '@type': Dataset
  description: 'Schematic drawing of different possible neuroprotective mechanisms
    exerted by hydrophilic bile acids, with specific reference to the anti-apoptotic
    effects of TUDCA on different intracellular pathways. Factors and pathways inhibited
    by TUDCA are shown in red; pathways blocked by TUDCA are shown by a red cross;
    genes downregulated by TUDCA are shown by a red downward arrow. Proposed mechanisms
    of action of TUDCA include: inhibition of the intrinsic mitochondrial apoptotic
    pathway, through reduction of ROS and inactivation of BAX, in turn decreasing
    cytochrome c release; inhibition of the death receptor in the extrinsic apoptotic
    pathway, with further block of caspase 3; reduction of ER-mediated stress by decreasing
    caspase 12 activity and Ca2+ efflux decrease from the ER. TUDCA also inhibits
    the apoptotic induced pathways MAPK, JNK, PI3K, NF-кB, ERK and p38 [–]. Furthermore,
    TUDCA is supposed to reduce the expression of genes involved in cell cycle regulation
    (Cyclin D1), the Apaf-1 apoptotic pathway, and the E2F/p53/BAX, and AP-1 pathways
    [, ]. Abbreviations: AKT, protein kinase B; AP1, activating Protein-1; Apaf-1,
    apoptotic protease activating factor-1; ATF2, activating transcription factor
    2; BAK, Bcl-2 homologous antagonist killer; BAX, Bcl2-associated X protein; Bcl-2,
    B-cell lymphoma 2 family of regulator proteins; BID, BH3 interacting-domain death
    agonist C, cytochrome C; CDC42, cell division control protein 42; E2F-1, E2 promoter
    binding factor 1; ERK, extracellular signal-regulated kinase; IKK-α, nuclear factor
    kappa-B kinase subunit alpha; IKK-β, nuclear factor kappa-B kinase subunit beta;
    IKK-γ, nuclear factor kappa-B kinase subunit gamma; JNK, c-Jun N-terminal kinase;
    KRAS, Kirsten rat sarcoma viral oncogene; MAPKs, mitogen-activated protein kinase;
    MOM, mitochondrial outer membrane; mTOR, mammalian target of rapamycin; NF-ĸB,
    nuclear factor kappa B; P, phosphate; p53, cellular tumour antigen p53; PI3K,
    phosphoinositide 3-kinases; RAC, Rho family of GTPases; RAS, rat Sarcoma Virus;
    SRF, serum response factor; tBID, truncated BID; TCF, transcription factor; TLR,
    Toll-like Receptor; TUDCA, tauroursodeoxycholic acid'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Bcl2
  - Bid
  - Bax
  - Bak1
  - Tp53
  - Srf
  - Ephb1
  - Cdc42
  - Mapk8
  - Map2k7
  - Atf2
  - Rho
  - Mapk14
  - Syt1
  - Rel
  - Npc2
  - Nfkb1
  - E2f1
  - Kras
  - Pik3cg
  - Akt1
  - Mtor
  - Nkx3-1
  - Trp53
  - ras
  - Hras
  - Rem1
  - Ephb2
  - Mapk1
  - Zhx2
  - Map2k2
  - Map3k1
  - Rhod
  - Ea2
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Ikbkb
  - Rela
  - Gorasp1
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Nfkbib
  - Pik3r1
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - BCL2
  - BID
  - TNFRSF10C
  - BAX
  - BAK1
  - TP53
  - TP63
  - TP73
  - KRAS
  - HRAS
  - NRAS
  - HNF4A
  - SRF
  - EPHB2
  - MAPK1
  - MAPK3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K2
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - CDC42
  - MAPK8
  - MAPK9
  - MAPK10
  - MAP3K1
  - MAP2K7
  - ATF2
  - GDNF
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - IKBKG
  - IKBKB
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - REL
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - NFKB1
  - E2F1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT2
  - AKT3
  - MTOR
  - mek-2
  - cdc-42
  - atf-2
  - Debcl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Fs(3)Bak
  - p53
  - betaTub60D
  - hth
  - dome
  - ca
  - Ras64B
  - Ras85D
  - pan
  - mal
  - bs
  - Erk7
  - rl
  - Raf
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - bsk
  - Mekk1
  - hep
  - Atf-2
  - CG44247
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - MKP-4
  - wnd
  - 18w
  - tok
  - tlr-2
  - key
  - IKKbeta
  - dl
  - wash
  - Hrb27C
  - Rpt5
  - DCTN2-p50
  - Dif
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Tor
---
